By targeting the CXCR4 pathway, our novel medicines are designed to restore healthy immunity in patients with rare diseases. In the short term (2weeks), XFOR's stock price should underperform the market by -3.42%.During that period the price should oscillate between -10.56% and +11.33%.. XFOR stock forecast Our latest prediction for X4 Pharmaceuticals Inc's stock price was made on the Feb. 2, 2021 when the stock price was at 7.95$.. The X4 Pharmaceuticals stock forecast is 12.470592 USD for 2022 March 07, Monday with technical analysis. Insiders buying/selling: X4 Pharmaceuticals Inc (NASDAQ:XFOR) In the past three months, X4 Pharmaceuticals insiders have sold more of their company’s stock than they have bought. Every day, we strive to advance our pipeline of innovative medicines to treat rare diseases. Find real-time IMMP - Immutep Ltd stock quotes, company profile, news and forecasts from CNN Business. Specifically, they have bought $0.00 in company stock and sold $20,160.00 in company stock. The average price target is $18.20, with a high forecast of $21.00 and a low forecast of $15.00. GlobeNewsWire - 2 months ago X4 Pharmaceuticals (XFOR) Surges: Stock Moves 6.9% Higher X4 Pharmaceuticals (XFOR) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes. X4 Pharmaceuticals (XFOR) stock price prediction is 12.470592 USD. XFOR | Complete X4 Pharmaceuticals Inc. stock news by MarketWatch. View recent trades and share price information for X4 Pharmaceuticals Inc and other shares. X4 Pharmaceuticals, Inc. Common Stock (XFOR) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Only 4.90% of the stock of X4 Pharmaceuticals is held by insiders. Find the latest X4 Pharmaceuticals, Inc. (XFOR) stock quote, history, news and other vital information to help you with your stock trading and investing. X4 Pharmaceuticals (NASDAQ:XFOR) last posted its quarterly earnings data on Thursday, November 5th. The latest X4 Pharmaceuticals Inc share price. Get the latest X4 Pharmaceuticals, Inc. XFOR detailed stock quotes, stock data, … This price target is based on 7 analysts offering 12 month price targets for X4 Pharmaceuticals in the last 3 months. View X4 Pharmaceuticals, Inc. XFOR investment & stock information. Our grit drives solutions for patients. The average price target represents a 184.38% upside from the last price of $6.40. View real-time stock prices and stock quotes for a full financial overview. Equities analysts forecast that X4 Pharmaceuticals will post -2.79 earnings per share for the current fiscal year. The company reported ($0.87) EPS for the quarter, missing analysts’ consensus estimates of ($0.74) by ($0.13).